Atlas Trials

Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL

Clinical trial NCT04994210 · UNKNOWN

Trial details

NCT number
NCT04994210
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Safety and Efficacy
Start date
2021-10-04
Primary completion
2023-08-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.